Susquehanna International Group, LLP Journey Medical Corp Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Journey Medical Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 57,339 shares of DERM stock, worth $403,093. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57,339
Previous 18,722
206.27%
Holding current value
$403,093
Previous $76,000
344.74%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DERM
# of Institutions
41Shares Held
5.9MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA1.85MShares$13 Million0.71% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT931KShares$6.54 Million0.03% of portfolio
-
B. Riley Securities, Inc. Los Angeles, CA865KShares$6.08 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA372KShares$2.62 Million0.0% of portfolio
-
Cambridge Investment Research Advisors, Inc.338KShares$2.38 Million0.01% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $81.5M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...